AMG National Trust Bank’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$9.06M Buy
65,010
+1,568
+2% +$220K 0.2% 79
2025
Q4
$7.79M Sell
63,442
-2,130
-3% -$259K 0.18% 81
2025
Q3
$7.28M Buy
65,572
+334
+0.5% +$38K 0.18% 85
2025
Q2
$7.23M Sell
65,238
-278
-0.4% -$29.6K 0.19% 82
2025
Q1
$7.34M Sell
65,516
-1,393
-2% -$144K 0.21% 81
2024
Q4
$6.16M Sell
66,909
-84
-0.1% -$7.56K 0.17% 85
2024
Q3
$5.62M Buy
66,993
+4,638
+7% +$354K 0.15% 92
2024
Q2
$4.28M Buy
62,355
+10,570
+20% +$705K 0.12% 121
2024
Q1
$3.79M Sell
51,785
-841
-2% -$64.7K 0.11% 118
2023
Q4
$4.26M Sell
52,626
-4,841
-8% -$377K 0.13% 107
2023
Q3
$4.31M Sell
57,467
-2,015
-3% -$155K 0.15% 96
2023
Q2
$4.58M Sell
59,482
-784
-1% -$62.5K 0.15% 101
2023
Q1
$5M Sell
60,266
-2,016
-3% -$167K 0.17% 86
2022
Q4
$5.35M Sell
62,282
-6,191
-9% -$490K 0.19% 79
2022
Q3
$4.22M Buy
68,473
+2,113
+3% +$133K 0.16% 100
2022
Q2
$4.08M Sell
66,360
-15,269
-19% -$945K 0.15% 95
2022
Q1
$4.85M Sell
81,629
-1,317
-2% -$84.2K 0.15% 87
2021
Q4
$6.02M Buy
82,946
+3,514
+4% +$242K 0.18% 71
2021
Q3
$5.55M Buy
79,432
+44,658
+128% +$3.14M 0.18% 74
2021
Q2
$2.4M Buy
34,774
+21,874
+170% +$1.46M 0.08% 154
2021
Q1
$834K Sell
12,900
-1,083
-8% -$69.8K 0.03% 292
2020
Q4
$815K Sell
13,983
-1,389
-9% -$83.8K 0.03% 282
2020
Q3
$971K Sell
15,372
-147
-0.9% -$10.2K 0.04% 234
2020
Q2
$1.19M Buy
+15,519
New +$1.19M 0.05% 198
2020
Q1
Sell
-74,817
Closed -$4.86M 252
2019
Q4
$4.86M Buy
74,817
+5,861
+8% +$382K 0.28% 51
2019
Q3
$4.37M Sell
68,956
-2,226
-3% -$146K 0.26% 53
2019
Q2
$4.81M Sell
71,182
-304
-0.4% -$20K 0.29% 51
2019
Q1
$4.65M Buy
71,486
+539
+0.8% +$35.8K 0.29% 47
2018
Q4
$4.44M Buy
70,947
+41,383
+140% +$2.89M 0.31% 44
2018
Q3
$2.28M Sell
29,564
-126
-0.4% -$9.52K 0.14% 90
2018
Q2
$2.1M Sell
29,690
-210
-0.7% -$14.8K 0.13% 93
2018
Q1
$2.25M Sell
29,900
-23
-0.1% -$1.83K 0.15% 87
2017
Q4
$2.14M Buy
29,923
+24
+0.1% +$1.82K 0.14% 92
2017
Q3
$2.42M Sell
29,899
-583
-2% -$44.6K 0.17% 80
2017
Q2
$2.16M Sell
30,482
-359
-1% -$23.9K 0.16% 88
2017
Q1
$2.09M Buy
30,841
+978
+3% +$68.8K 0.16% 87
2016
Q4
$2.14M Buy
29,863
+5,258
+21% +$391K 0.18% 79
2016
Q3
$1.95M Buy
24,605
+8,194
+50% +$666K 0.17% 73
2016
Q2
$1.37M Buy
16,411
+3,713
+29% +$330K 0.12% 95
2016
Q1
$1.17M Sell
12,698
-998
-7% -$90K 0.11% 111
2015
Q4
$1.39M Sell
13,696
-9,667
-41% -$1.01M 0.13% 101
2015
Q3
$2.29M Sell
23,363
-480
-2% -$53.3K 0.22% 62
2015
Q2
$2.79M Sell
23,843
-587
-2% -$64.1K 0.26% 57
2015
Q1
$2.4M Buy
24,430
+139
+0.6% +$14.1K 0.23% 65
2014
Q4
$2.29M Sell
24,291
-935
-4% -$96.7K 0.23% 62
2014
Q3
$2.69M Sell
25,226
-2,826
-10% -$277K 0.28% 61
2014
Q2
$2.33M Sell
28,052
-545
-2% -$42.4K 0.24% 69
2014
Q1
$2.03M Sell
28,597
-211
-0.7% -$16.5K 0.22% 77
2013
Q4
$2.16M Sell
28,808
-15,386
-35% -$1.07M 0.24% 56
2013
Q3
$2.78M Sell
44,194
-719
-2% -$43K 0.35% 49
2013
Q2
$2.3M Buy
+44,913
New +$2.34M 0.31% 54

Other funds holding GILD

AMG National Trust Bank's GILD Position: Q1 2026 in Review

AMG National Trust Bank increased its Gilead Sciences (GILD) stake by 2.5% in Q1 2026, buying an estimated $220K and bringing the position to 65,010 shares worth $9.06M. The position accounts for 0.2% of the portfolio, ranked #79.

AMG National Trust Bank first reported a position in GILD in Q2 2013 and has held it in 51 quarters since. 2,311 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • AMG National Trust Bank held 65,010 shares of Gilead Sciences worth $9.06M as of Q1 2026.
  • AMG National Trust Bank bought 1,568 Gilead Sciences shares in Q1 2026, an estimated $220K.
  • Gilead Sciences made up 0.2% of AMG National Trust Bank's portfolio in Q1 2026, its #79 holding.
  • AMG National Trust Bank first reported a position in Gilead Sciences in Q2 2013 and has held it in 51 quarters since.
  • 2,311 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on AMG National Trust Bank's 13F filing for Q1 2026, filed 4 May 2026.